Focal Epilepsy
Focal epilepsy is a type of epilepsy where seizures start in a specific area of the brain, leading to various symptoms depending on the affected region. It can sometimes be difficult to control with medication.
Refractory Focal Onset Epilepsy: BHV-7000 Study
We are testing a new medication, BHV-7000, to see if it can help reduce seizures in adults with refractory focal onset epilepsy. The study compares its effects to a placebo to evaluate safety and effectiveness.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have a diagnosis of focal onset epilepsy?
- Have you tried at least two different anti-seizure medications without success?
- Are you currently taking at least one anti-seizure medication?
- Have you had any seizures that lasted longer than 5 minutes in the last 6 months?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Bhv-7000
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Region Midtjylland
Department of Neurology, Neurological Research Unit
Århus, Denmark
Odense University Hospital
Neurologisk Afdeling N
Odense, Denmark
Filadelfia
Danish Epilepsy Center, Filadelfia Adult Department
Sorø, Denmark
Sponsor: Biohaven Therapeutics Ltd.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.